InvestorsHub Logo
Followers 13
Posts 865
Boards Moderated 0
Alias Born 02/17/2017

Re: docz21321312 post# 39038

Friday, 03/22/2019 1:07:03 PM

Friday, March 22, 2019 1:07:03 PM

Post# of 232169
Anything is possible. I tend to think that their confidence in this trial is extremely high - with good reason - and IF there’s a strategic delay it would be because they want to get a deal done first so that they might be able to uplist prior to interim cancer results.

That said, I think the possibility of a strategic delay as described in theory by either of us is highly unlikely. I’d bet a house that, due to their level of confidence, they’re just making sure that the trial results will be unassailable from any potential angle. They’re certainly hoping to apply for AA from the P2 portion, and would be wise to head off any technical challenges that would warrant a further ask by the FDA. NP most likely overpromised on the original deadline for the first injection.

But like I said, anything is possible. A boss of mine used to tell me all the time... “as long as you were thinking when you did that...” I feel the same way about the company. As long as they’re thinking about what they’re doing and why, I’m ok with it. And I believe they’re thinking about things very hard right now.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News